WHO　2020/9/22まとめ

　

 赤字は中国企業                                                         　　IM＝Intramuscular 筋肉注射　ID＝intradermal　皮内注射

Developer/manufacturer	Platform	Type	doses	Timing	Route	Phase
						1	1/2	2	3
University of Oxford/AstraZeneca	Non-Replicating Viral Vector	ChAdOx1-S	1		IM		〇	〇	〇
CanSinoBiological Inc./Beijing Institute of Biotechnology	Non-Replicating Viral Vector	Adenovirus Type 5 Vector	1		IM	〇		〇	〇
Gamaleya Research Institute（ロシア）	Non-Replicating Viral Vector	Adeno-based	2	0, 21 days	IM	〇			〇
Janssen Pharmaceutical (J&J)	Non-Replicating Viral Vector	Ad26COVS1	2	0,56 days	IM		〇		〇
Sinovac（中国）	Inactivated	Inactivated	2	0, 14 days	IM		〇		〇
Wuhan Institute of Biological Products/Sinopharm	Inactivated	Inactivated	2	0,14 or 0,21 days	IM		〇		〇
Beijing Institute of Biological Products/Sinopharm	Inactivated	Inactivated	2	0,14 or 0,21 days	IM		〇		〇
Moderna/NIAID（米国立アレルギー感染症研究所）	RNA	LNP-encapsulated mRNA	2	0, 28 days	IM	〇		〇	〇
BioNTech（独）/Fosun Pharma（上海復星医薬）/Pfizer     　〔前2社が提携〕	RNA	3 LNP-mRNAs	2	0, 28days	IM		〇		〇
Novavax（米）	Protein Subunit	Full length recombinant SARS CoV-2 glycoprotein nanoparticle vaccine adjuvanted with Matrix M	2	0, 21 days	IM		〇	〇
Anhui Zhifei Longcom Biopharmaceutical/Institute of Microbiology, Chinese Academy of Sciences	Protein Subunit	Adjuvanted recombinant protein (RBD-Dimer)	2 or 3	0,28 or 0,28,56 days	IM	〇	〇	〇
Curevac（独）	RNA	mRNA	2	0, 28 days	IM	〇		〇
Institute of Medical Biology, Chinese Academy of Medical Sciences	Inactivated	Inactivated	2	0, 28 days	IM	〇	〇
Research Institute fo Bological Safety Problems, Rep. of Kazakhstan	Inactivated	Inactivated	2	0, 21 days	IM		〇
InovioPharmaceuticals(米）/ International Vaccine Institute	DNA	DNA plasmid vaccine with electroporation	2	0, 28 days	ID		〇
Osaka University/ AnGes/ Takara Bio	DNA	DNA plasmid vaccine + Adjuvant	2	0, 14 days	IM		〇
Cadila Healthcare(インド）	DNA	DNA plasmid vaccine	3	0, 28, 56 days	ID		〇
Genexine Consortium(韓国）	DNA	DNA Vaccine (GX-19)	2	0, 28 days	IM		〇
Bharat Biotech　（インド）	Inactivated	Whole-Virion Inactivated	2	0, 14 days	IM		〇
Kentucky Bioprocessing（米）	Protein Subunit	RBD-based	2	0, 21 days	IM		〇
Sanofi Pasteur/GSK	Protein Subunit	S Protein (baculovirus production)	2	0, 21 days	IM		〇
Arcturus（米）/Duke-NUS（シンガポール）	RNA	mRNA			IM		〇
ReiThera（伊）/LEUKOCARE（独）/Univercells（ベルギー）	Non-Replicating Viral Vector	Replication defective Simian Adenovirus (GARs) encoding S	1		IM	〇
Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China	Non-Replicating Viral Vector	Ad5-nCoV	2	0, 28 days	IM/mucosal	〇
Clover Biopharmaceuticals Inc./GSK/Dynavax	Protein Subunit	Native like Trimeric subunit Spike Protein vaccine	2	0, 21 days	IM	〇
Vaxine Pty Ltd（豪）/Medytox（韓）	Protein Subunit	Recombinant spike protein with Advax™ adjuvant	1		IM	〇
University of Queensland/CSL（豪）/Seqirus（英）	Protein Subunit	Molecular clamp stabilized Spike protein with MF59 adjuvant	2	0, 28 days	IM	〇
Medigen Vaccine Biologics（台湾）/NIAID/Dynavax	Protein Subunit	S-2P protein + CpG 1018	2	0, 28 days	IM	〇
Instituto Finlay de Vacunas, Cuba	Protein Subunit	PBD + Adjutant	2	0, 28 days	IM	〇
FBRI SRC VB Vector, Rospotrebnadzor, Koltsovo Russia	Protein Subunit	Reptide	2	0, 21days	IM	〇
West China Hospital, Sichuan University	Protein Subunit	PBD (baculovirus production expressed in Sf9 cells)	2	0, 28 days	IM	〇
University Hospital Tuebingen	Protein Subunit	SARS-CoV-2 HLA-DR peptides	1		SC	〇
COVAXX (United Biomedical )	Protein Subunit	S1-RBD-protein	2	0, 28 days	IM	〇
Institute Pasteur/Themis/Univ. of Pittsburg CVR/Merck Sharp & Dohme	Replicating Viral Vector	Measles-vector based	1 or 2	0, 28 days	IM	〇
Beijing Wantai Biological Pharmacy/ Xiamen University	Replicating Viral Vector	Intranasal flu-based-RBD	1		IM	〇
Imperial College London	RNA	LNP-nCoVsaRNA	2		IM	〇
People's Liberation Army (PLA) Academy of Military Sciences/Walvax Biotech（云南沃森生物）	RNA	mRNA	2	0, 14 or 0, 28 days	IM	〇
Medicago（カナダ　田辺三菱製薬）	VLP	Plant-derived VLP adjuvanted with GSK or Dynavax adjs.	2	0, 21 days	IM	〇